AUD 0.02
(4.55%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 8.96 Million AUD | -37.32% |
2023 | 14.29 Million AUD | -6.38% |
2022 | 15.27 Million AUD | -36.89% |
2021 | 24.2 Million AUD | 30.67% |
2020 | 18.52 Million AUD | -24.2% |
2019 | 24.43 Million AUD | -24.8% |
2018 | 32.49 Million AUD | -31.32% |
2017 | 47.3 Million AUD | -11.36% |
2016 | 53.37 Million AUD | 10.05% |
2015 | 48.49 Million AUD | -8.88% |
2014 | 53.22 Million AUD | 0.62% |
2013 | 52.89 Million AUD | -9.58% |
2012 | 58.49 Million AUD | -0.84% |
2011 | 58.99 Million AUD | -29.44% |
2010 | 83.6 Million AUD | 139.21% |
2009 | 34.95 Million AUD | -15.31% |
2008 | 41.26 Million AUD | 102.6% |
2007 | 20.36 Million AUD | -12.33% |
2006 | 23.23 Million AUD | -25.28% |
2005 | 31.09 Million AUD | 218.66% |
2004 | 9.75 Million AUD | -24.04% |
2003 | 12.84 Million AUD | -30.02% |
2002 | 18.35 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 9.95 Million AUD | -30.39% |
2024 Q4 | 8.96 Million AUD | 0.0% |
2024 Q2 | 12.01 Million AUD | 0.0% |
2023 FY | 14.29 Million AUD | -6.38% |
2023 Q4 | 14.29 Million AUD | 0.0% |
2023 Q2 | 10.36 Million AUD | 0.0% |
2022 Q4 | 15.27 Million AUD | 0.0% |
2022 FY | 15.27 Million AUD | -36.89% |
2022 Q2 | 17.16 Million AUD | 0.0% |
2021 Q4 | 24.2 Million AUD | 0.0% |
2021 FY | 24.2 Million AUD | 30.67% |
2021 Q2 | 17.62 Million AUD | 0.0% |
2020 FY | 18.52 Million AUD | -24.2% |
2020 Q2 | 20.08 Million AUD | 0.0% |
2020 Q4 | 18.52 Million AUD | 0.0% |
2019 Q2 | 28.47 Million AUD | 0.0% |
2019 Q4 | 24.43 Million AUD | 0.0% |
2019 FY | 24.43 Million AUD | -24.8% |
2018 FY | 32.49 Million AUD | -31.32% |
2018 Q4 | 32.49 Million AUD | 0.0% |
2018 Q2 | 37.16 Million AUD | 0.0% |
2017 Q2 | 58.45 Million AUD | 0.0% |
2017 FY | 47.3 Million AUD | -11.36% |
2017 Q4 | 47.3 Million AUD | 0.0% |
2016 Q4 | 53.37 Million AUD | 0.0% |
2016 FY | 53.37 Million AUD | 10.05% |
2016 Q2 | 49.7 Million AUD | 0.0% |
2015 FY | 48.49 Million AUD | -8.88% |
2015 Q4 | 48.49 Million AUD | 0.0% |
2015 Q2 | 45.14 Million AUD | 0.0% |
2014 FY | 53.22 Million AUD | 0.62% |
2014 Q4 | 53.22 Million AUD | 0.0% |
2014 Q2 | 76.69 Million AUD | 0.0% |
2013 Q4 | 52.89 Million AUD | 0.0% |
2013 FY | 52.89 Million AUD | -9.58% |
2013 Q2 | 46.36 Million AUD | 0.0% |
2012 FY | 58.49 Million AUD | -0.84% |
2012 Q4 | 58.49 Million AUD | 0.0% |
2011 Q4 | 58.99 Million AUD | 0.0% |
2011 FY | 58.99 Million AUD | -29.44% |
2010 Q4 | 83.6 Million AUD | 0.0% |
2010 FY | 83.6 Million AUD | 139.21% |
2009 Q4 | 34.95 Million AUD | 0.0% |
2009 FY | 34.95 Million AUD | -15.31% |
2008 FY | 41.26 Million AUD | 102.6% |
2008 Q4 | 41.26 Million AUD | 0.0% |
2007 FY | 20.36 Million AUD | -12.33% |
2007 Q4 | 20.36 Million AUD | 0.0% |
2006 Q4 | 23.23 Million AUD | 0.0% |
2006 FY | 23.23 Million AUD | -25.28% |
2005 FY | 31.09 Million AUD | 218.66% |
2005 Q4 | 31.09 Million AUD | 0.0% |
2004 FY | 9.75 Million AUD | -24.04% |
2004 Q4 | 9.75 Million AUD | 0.0% |
2003 FY | 12.84 Million AUD | -30.02% |
2002 FY | 18.35 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AdAlta Limited | 5.57 Million AUD | -60.829% |
Actinogen Medical Limited | 21.31 Million AUD | 57.944% |
AnteoTech Limited | 9.38 Million AUD | 4.458% |
Argenica Therapeutics Limited | 16.37 Million AUD | 45.273% |
Arovella Therapeutics Limited | 13.28 Million AUD | 32.531% |
Anatara Lifesciences Ltd | 1.67 Million AUD | -436.25% |
Alterity Therapeutics Limited | 19.22 Million AUD | 53.375% |
Amplia Therapeutics Limited | 14.84 Million AUD | 39.623% |
Avecho Biotechnology Limited | 7.31 Million AUD | -22.457% |
Bio-Gene Technology Limited | 3.15 Million AUD | -183.676% |
Biome Australia Limited | 8.27 Million AUD | -8.291% |
Biotron Limited | 493.47 Thousand AUD | -1716.299% |
Botanix Pharmaceuticals Limited | 112.46 Million AUD | 92.03% |
BTC Health Limited | 5.14 Million AUD | -74.079% |
Chimeric Therapeutics Limited | 15.27 Million AUD | 41.315% |
CSL Limited | 56.93 Billion AUD | 99.984% |
Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 94.204% |
Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 96.122% |
Cynata Therapeutics Limited | 8.38 Million AUD | -6.851% |
Dimerix Limited | 32.07 Million AUD | 72.059% |
EZZ Life Science Holdings Limited | 25.55 Million AUD | 64.922% |
Hexima Limited | 2.26 Million AUD | -295.019% |
Island Pharmaceuticals Limited | 2.56 Million AUD | -249.507% |
Immuron Limited | 15.54 Million AUD | 42.36% |
Immutep Limited | 147.44 Million AUD | 93.921% |
Imugene Limited | 151.39 Million AUD | 94.08% |
Invex Therapeutics Ltd | 6.12 Million AUD | -46.453% |
Memphasys Limited | 12.43 Million AUD | 27.893% |
Nanollose Limited | 241.95 Thousand AUD | -3604.469% |
Neuren Pharmaceuticals Limited | 247.97 Million AUD | 96.385% |
Noxopharm Limited | 6.78 Million AUD | -32.124% |
NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -64.886% |
Nyrada Inc. | 5.9 Million AUD | -51.728% |
Orthocell Limited | 26.61 Million AUD | 66.324% |
PharmAust Limited | 11.12 Million AUD | 19.433% |
Patrys Limited | 4.16 Million AUD | -115.375% |
Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 67.277% |
Proteomics International Laboratories Limited | 10.87 Million AUD | 17.582% |
Prescient Therapeutics Limited | 20.39 Million AUD | 56.048% |
PYC Therapeutics Limited | 91.23 Million AUD | 90.176% |
Race Oncology Limited | 20.22 Million AUD | 55.691% |
Radiopharm Theranostics Limited | 72.03 Million AUD | 87.558% |
Recce Pharmaceuticals Ltd | 6.36 Million AUD | -40.715% |
Starpharma Holdings Limited | 36.81 Million AUD | 75.653% |
Telix Pharmaceuticals Limited | 398.3 Million AUD | 97.75% |
Tissue Repair Ltd | 19.38 Million AUD | 53.774% |
Zelira Therapeutics Limited | 5.18 Million AUD | -72.917% |